Clinical trial
Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy…
NCT00417196 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00417196 |
|---|---|
| Title | Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers. |
| Official title | A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Single Escalating Doses of Intravenous QAX576 |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | QAX576 |
| Enrollment | 32 |
| Start date | Dec 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Dec 29, 2006 |
| Last update posted | Oct 1, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: